Status:

COMPLETED

Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

National Institute on Minority Health and Health Disparities (NIMHD)

Conditions:

Breast Cancer Screening

Oncology

Eligibility:

FEMALE

40-49 years

Phase:

NA

Brief Summary

The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The i...

Eligibility Criteria

Inclusion

  • Latina, Black, or non-Latina White women
  • Between the ages of 40-49 years
  • Can write, read, and understand English

Exclusion

  • Women with greater than an average self-reported risk of breast cancer will be ineligible for participation, as evidenced by any of the following:
  • Self-reported personal history of breast cancer (invasive, ductal carcinoma in situ \[DCIS\], or lobular carcinoma in situ\[LCIS\])
  • Self-reported personal history of atypical hyperplasia
  • Self-reported first degree family member with history of breast cancer (e.g., mother, sister)
  • Self-reported known underlying genetic mutation such as a BRCA1/BRCA2 gene
  • Self-reported prior thoracic or chest wall radiation therapy

Key Trial Info

Start Date :

April 19 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2021

Estimated Enrollment :

1277 Patients enrolled

Trial Details

Trial ID

NCT04741503

Start Date

April 19 2021

End Date

August 30 2021

Last Update

September 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110